首页|桂枝甘草汤对冠心病患者心功能及血清VCAM-1、sE-selectin水平的影响

桂枝甘草汤对冠心病患者心功能及血清VCAM-1、sE-selectin水平的影响

扫码查看
目的 分析桂枝甘草汤对冠心病患者心功能及血清VCAM-1、sE-selectin水平的影响.方法 选择2014年9月~2015年6在浙江省杭州市中医院收治冠心病患者80例为研究对象,依据治疗方法不同,采用常规西药治疗患者40例为对照组,采用常规西药治疗基础上联合桂枝甘草汤治疗患者40例为观察组.观察2组患者心功能疗效、心动图参数及血清sE-Selectin,ICAM-1水平及6 min步行试验.结果 观察组患者心脏超声各参数LVEF(43.27±5.21)%,LVEDd(59.34±5.43)mm,?FS(26.32±1.63)%,E/A(1.23±0.22)及6 min步行距离均优于对照组对应指标(t=2.3628,P=0.0206;t=2.4643,P=0.0159;t=2.7831,P=0.0068;t=2.5023,P=0.0144;t=3.7571,P=0.0006).观察组患者心功能指标显效19例,显效率为47.50%,高于对照组的25.00%,对比有明显差异(χ2=4.3813,P=0.0363).观察组患者无效4例,无效率为10.00%,远低于对照组的27.50%(χ2=4.0205,P=0.0450).观察组患者血脂指标TC(5.21±0.82)mmol/L、TG(1.22±0.32)mmol/L及LDL-C(2.44±0.52)mmol/L均明显低于对照组(t=3.2729,P=0.0016;t=3.5119,P=0.0007;t=3.5136,P=0.0007),而HDL-C(1.21±0.17)mmol/L指标高于对照组(t=5.4575,P=0.0000).2组患者治疗前血清指标对比差异无统计学意义.在治疗后,观察组患者血清sE-Selectin(75.58±9.97)ng/mL,VCAM-1(662.43±65.78)ng/mL均低于对照组(t=3.4082,P=0.0010;t=3.3088,P=0.0014).结论 在西医治疗基础上,辅助中药桂枝甘草汤可以明显增强冠心病患者的心功能,疗效突出,同时也可以改善患者血脂及sE-Selectin、VCAM-1水平,从而最终改善患者病情.
Effect of Guizhi Gancao decoction on cardiac function and serum VCAM-1 and sE-selectin levels in patients with coronary heart disease
Objective To analyze the effect of guizhi gancao decoction on dardiac function and serum VCAM-1 and sE-selectin levels in patients with coronary heart diseaser. Methods Fifty-eight patients with coronary heart disease were enrolled in this study from September 2014 to June 2015. According to the different treatment methods, 40 patients were treated with conventional western medicine. The observation group of 40 cases were treated with conventional western medicine and Guizhi licorice soup. The effects of cardiac function, 6-minute walking test, cardiac parameters and serum sE-Selectin and ICAM-1 levels were observed. Results Observation group of patients with cardiac ultrasound parameters LVEF (43.27 ± 5.21)%, LVEDd (59.34 ± 5.43) mm, FS (26.32 ± 1.63)%, E / A (1.23 ± 0.22) and 6 min walking distance were better than those of the control group (t=2.3628,P =0.0206;t=2.4643,P=0.0159;t=2.7831,P =0.0068;t=2.5023,P =0.0144;t=3.7571,P =0.0006). The markedly effective rate was 47.50%, which was higher than that of the control group (25.00%), and there was significant difference (χ2 = 4.3813, P= 0.0363). In the observation group, 4 patients were ineffective and the inefficiency rate was 10.00%, which was significantly lower than that of the control group (χ2 = 4.0205,P= 0.0450). The levels of TC (5.21 ± 0.82) mmol / L, TG (1.22 ± 0.32) mmol / L and LDL-C (2.44 ± 0.52) mmol / L were significantly lower in the observation group than those in the control group (t= 3.2729, P = 0.0016; t= 3.5119, P = 0.0007; t= 3.5136, P= 0.0007). While the HDL-C (1.21 ± 0.17) mmol / L index was higher than that of the control group (t = 5.4575, P = 0.0000). There was no significant difference in serum index between the two groups before treatment . After treatment, the serum sE-Selectin (75.58 ± 9.97) ng / mL and VCAM-1 (662.43 ± 65.78) ng / mL were lower than those in the control group (t = 3.4082, P = 0.0010;t = 3.3088, P = 0.0014). Conclusion Treatment of CHF patients with CRT / CRT-D pacemaker implantation in the heart after surgery can effectively improve its clinical condition, and the effect is outstanding, side effects, and CRT-D better effect.

Guizhi licorice soupcoronary heart diseasecardiac functionVCAM-1sE-selectin

游丽娟、王鑫昱、张洁

展开 >

浙江省杭州市中医院,浙江 杭州 310007

杭州民生药业有限公司,浙江 杭州 310011

桂枝甘草汤 冠心病 心功能 VCAM-1 sE-selectin

2017

中国生化药物杂志
南京生物化学制药研究所,全国生化制药情报中心站,中国生化制药工业协会,中国药品生物制品检定所

中国生化药物杂志

ISSN:1005-1678
年,卷(期):2017.37(8)
  • 3
  • 11